CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ½ÅÁ¤¿ø
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ³úÀüÁõ(°æ·Ã¼ºÁúȯ)/½Ç½Å/¼ö¸éÀå¾Ö/ÀÎÁöÀúÇÏ/³ú¿°
  • Á÷ À§: Á¶±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
180 (±¹¿Ü)SCI Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study
179 (±¹³»)SCIE The Effect of Pulsatility Index on Infarct Volume in Acute Lacunar Stroke.
178 (±¹³»)SCOPUS BÇü°£¿° ȯÀÚ¿¡¼­ ¿£Å×Ä«ºñ¾î Åõ¿© ÈÄ ¹ß»ýÇÑ ÁßÁõ ´Ù¹ß¼º ½Å°æº´Áõ
177 (±¹¿Ü)SCI Prognostic Value of Initial Standard EEG and MRI in Patients with Herpes Simplex Encephalitis
176 (±¹¿Ü)SCIE Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial
175 (±¹¿Ü)SCIE Association between Serum Alkaline Phosphatase Level and Cerebral Small Vessel Disease.
174 (±¹¿Ü)±âŸ Association between eNOS polymorphisms and risk of coronary artery disease in a Korean population: a meta-analysis.
173 (±¹¿Ü)SCIE Factors contributing to the development of perceived stigma in people with newly diagnosed epilepsy: A one-year longitudinal study.
172 (±¹¿Ü)SCIE The effect of recurrent seizures on cognitive, behavioral, and quality-of-life outcomes after 12months of monotherapy in adults with newly diagnosed or previously untreated partial epilepsy.
171 (±¹¿Ü)SCI The complexity of diagnosing postural orthostatic tachycardia syndrome: influence of the diurnal variability.
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 17 18 19 20 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729